Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hashimoto's thyroiditis (HT) is an important factor that affects the prognosis of papillary thyroid carcinoma (PTC).
|
31686862 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Papillary thyroid cancer (80% of thyroid cancer) whose incidence is increasing worldwide, is associated with Hashimoto's thyroiditis.
|
31698655 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Papillary thyroid cancer with coexisting Hashimoto's thyroiditis presents elevated MHC class I expression, which may be the result of IL-17A secretion.
|
31159823 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The results showed that the elevated CK-19 expression, and the presence of BRAF mutations and RET/PTC rearrangements were indicators of multifocal PTC in HT, suggesting the need for total bilateral thyroidectomy.
|
31497359 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A total of 246 cases of thyroid disease were collected, including PTC, PTMC, nodular goiter (NG) and Hashimoto thyroiditis (HT).
|
29541194 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Because Hashimoto's thyroiditis may influence the diagnostic performance, a subgroup was also analysed that included only lymph nodes from PTC without Hashimoto's thyroiditis.
|
30342491 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Of the 533 enrolled patients, 159 (29.8%) were diagnosed with PTC, of which 38 (35.5%) had Hashimoto's thyroiditis (HT).
|
28951739 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The association between Hashimoto thyroiditis (HT) and papillary thyroid carcinoma (PTC) has been originally suggested by retrospective pathological studies and has recently been re-evaluated and proposed on the basis of several fine-needle aspiration cytology (FNAC) studies.
|
28868258 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
One hundred five cases composed of 34 follicular nodular disease (FND), 31 Hashimoto's thyroiditis (HT), and 40 papillary thyroid carcinoma (PTC) were compiled retrospectively.
|
28440063 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
It remains unknown whether the coexistence of RTH with papillary thyroid carcinoma (PTC) and Hashimoto thyroiditis (HT) is incidental or whether it possesses a genetic or pathophysiological association.
|
28928829 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk.
|
28977955 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
GWAS-identified SNPs affect the individual predisposition to PTC without interacting with existing Hashimoto thyroiditis and BTT lesions.
|
25746573 |
2015 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
For immunohistochemistry, a tissue microarray was generated that contained the following tissues: classic PTC (n = 20), follicular variant of PTC (n = 9), normal thyroid (n = 19), Hashimoto thyroiditis (n = 11), follicular adenoma (n = 15), and follicular carcinoma (n = 14).
|
18261626 |
2008 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We also observed similarities in the E-cadherin expression profiles of Hashimoto thyroiditis and ret/PTC-1-positive papillary thyroid carcinomas and have hypothesized that ret/PTC-1 activation might cause not only the structural and nuclear peculiarities of PTC but also an immune reaction to thyroid epithelium.
|
12605035 |
2003 |